Development of human neutralizing monoclonal antibodies for prevention and therapy of MERS-CoV infections

Development of human neutralizing monoclonal antibodies for prevention and therapy of MERS-CoV infections

Item
http://www.wikidata.org/entity/Q35019893
Development of Medical Countermeasures to Middle East Respiratory Syndrome CoronavirusCritically ill patients with Middle East respiratory syndrome coronavirus infectionFrom SARS to MERS: evidence and speculation.A review of treatment modalities for Middle East Respiratory Syndrome.Junctional and allele-specific residues are critical for MERS-CoV neutralization by an exceptionally potent germline-like antibody.Treatment strategies for Middle East respiratory syndrome coronavirus.3B11-N, a monoclonal antibody against MERS-CoV, reduces lung pathology in rhesus monkeys following intratracheal inoculation of MERS-CoV Jordan-n3/2012The heptad repeat region is a major selection target in MERS-CoV and related coronaviruses.Middle East respiratory syndrome coronavirus M protein suppresses type I interferon expression through the inhibition of TBK1-dependent phosphorylation of IRF3.Infection with Middle East respiratory syndrome coronavirus.Urgent development of effective therapeutic and prophylactic agents to control the emerging threat of Middle East respiratory syndrome (MERS).Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome: Current Therapeutic Options and Potential Targets for Novel Therapies.
P2860

Development of human neutralizing monoclonal antibodies for prevention and therapy of MERS-CoV infections

Item
http://www.wikidata.org/entity/Q35019893
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Development of human neutraliz ...... therapy of MERS-CoV infections
@ast
Development of human neutraliz ...... therapy of MERS-CoV infections
@en
type
label
Development of human neutraliz ...... therapy of MERS-CoV infections
@ast
Development of human neutraliz ...... therapy of MERS-CoV infections
@en
prefLabel
Development of human neutraliz ...... therapy of MERS-CoV infections
@ast
Development of human neutraliz ...... therapy of MERS-CoV infections
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P921
P932
P356
P1433
P1476
Development of human neutraliz ...... therapy of MERS-CoV infections
@en
P2093
P2860
P304
P31
P356
10.1016/J.MICINF.2014.11.008
P433
P478
P50
P577
P698
P921
P932